Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Rare diseases 10

Rare Diseases

Pharma News for CG Oncology, Amgen, Elevar, and GSK

Notizia - Recent Pharma, Healthcare and Biotech Happenings

CG Oncology Teams Up With Merck & BMS; Parse Biosciences Partners With Molecular Diagnostics Korea; Amgen’s Olpasiran; Elevar Therapeutics Announces Results of Rivoceranib; FDA Approves GSK’s Measles Vaccine; Sage & Biogen Reveals Postpartum Depression Trial Result

FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years GSK announced that the company's vaccine for protection against mumps, measles, and rubella (MMR) had been approved by the U.S. FDA. According to data from six clinical studies, the company filed a Biologics License Application in August 2021. GSK's MMR vaccine first met with regulatory approval in 1997, when the biologic was approved for marketing in Germany. Since then, it has been approved in every European country and Canada, Australia, and New Zealand. Clinical trials included approximately 17,000 participants from each vaccination age group (12 to 15 months, 4 to 6 years old, and over seven...

Explore More...

Acromegaly Pipeline | Acromegaly Companies |Therapies

What Does The Acromegaly Pipeline Have Up In Its Sleeve?

Dravet Syndrome Market | Dravet Syndrome Pipeline

The Rarity Of Dravet Syndrome: Challenges, and Treatments

pharma news

Sanofi acquires Principia; FDA’s Nod to Roche’s Enspryng; BMS, Dragonfly’s Licensing Deal

Latest pharma happenings for Roche and Secura Bio

FDA’s Ok to Roche’s Oral SMA Therapy; Roche’s Etrolizumab Mixed Results in Ulcerative Colitis; Secura receives rights to Copiktra from Verastem

Adrenoleukodystrophy Market | ALD Market

A Complex Chromosomal Abberation Called Adrenoleukodystrophy

latest pharma news

AZ, Daiichi inks an oncology deal; Moderna begins Phase III trial of its COVID-19 vaccine; No good news for Solid’s DMD gene therapy trial

Huntington’s disease Market

Is the cure for Huntington’s disease on the horizon?

pharma-news

Avrobio taps Magenta’s ADC; Eli Lilly ramps up; FDA postpones decision; CSL gears up to fight pandemic,

Anaphylaxis

Anaphylaxis: A Rare Disease

Angelman syndrome

Angelman syndrome: A Rare Genetic Disorder

pharma news

Roche, Sarepta collaborates; FDA approval for Merck’s Ervebo, and Allergan’s Ubrelvy

pharma news

Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Fragile X Syndrome Market

Fragile X Syndrome Market

Pharma News

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Gaucher disease Market

Gaucher disease Market Analysis: Rich Pipeline Drives the Market Ahead

Rare disease

Are Rare Diseases truly Rare?

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly